MarketCap
Facebook
X
TelegramIntersect ENT, Inc. ROA Ratio 2011-2026 | XENT
Annual ROA Ratio Intersect ENT, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -31.81 | -29.07 | -16.26 | -12.07 | -19.43 | -18.41 | -29.17 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -12.07 | -31.81 | -22.32 |
ROA Ratio of other stocks in the Medical devices industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alphatec Holdings
ATEC
|
-18.12 | $ 11.75 | -3.29 % | $ 1.76 B |  USA |
 |
BioSig Technologies
BSGM
|
-1226.84 | - | 37.08 % | $ 85.7 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-8.34 | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-9.05 | - | - | $ 3.31 B | USA |
 |
Delcath Systems
DCTH
|
2.18 | $ 8.98 | -1.32 % | $ 322 M | USA |
 |
Lianluo Smart Limited
LLIT
|
-53.6 | - | 24.59 % | $ 44.8 M |  China |
 |
Aziyo Biologics
AZYO
|
85.61 | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
-151.34 | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-9.84 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-116.17 | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
-56.51 | - | -0.97 % | $ 54.4 M | USA |
 |
FONAR Corporation
FONR
|
6.24 | $ 18.41 | 0.38 % | $ 121 M | USA |
 |
Conformis
CFMS
|
-53.67 | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
-11.45 | - | 0.15 % | $ 844 M | USA |
 |
Inogen
INGN
|
-7.62 | $ 6.32 | -2.02 % | $ 168 M | USA |
 |
Apollo Endosurgery
APEN
|
-36.14 | - | - | $ 475 M | USA |
 |
IRIDEX Corporation
IRIX
|
-27.79 | $ 1.35 | - | $ 21.8 M | USA |
 |
IRadimed Corporation
IRMD
|
20.67 | $ 100.97 | 1.78 % | $ 1.28 B | USA |
 |
Avinger
AVGR
|
-133.04 | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
-2.11 | - | -4.14 % | $ 702 M | USA |
 |
LivaNova PLC
LIVN
|
-9.3 | $ 62.4 | -1.33 % | $ 3.4 B |  Britain |
 |
LENSAR
LNSR
|
-47.37 | $ 5.56 | -8.4 % | $ 64 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-323.35 | - | 1.15 % | $ 34.5 M | USA |
 |
AxoGen
AXGN
|
-7.08 | $ 32.61 | 2.71 % | $ 1.5 B | USA |
 |
CONMED Corporation
CNMD
|
2.02 | $ 36.56 | -0.19 % | $ 1.13 B | USA |
 |
Medtronic PLC
MDT
|
5.09 | $ 86.58 | -0.68 % | $ 111 B | USA |
 |
Soliton, Inc.
SOLY
|
-43.02 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-86.69 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-17.05 | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
-102.09 | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
14.01 | $ 24.7 | 0.86 % | $ 209 M | USA |
 |
Misonix, Inc.
MSON
|
-8.55 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-37.58 | - | - | $ 111 M |  Canada |
 |
InspireMD
NSPR
|
-70.29 | $ 1.79 | 3.47 % | $ 115 M | Israel |
 |
Orthofix Medical
OFIX
|
-10.84 | $ 11.72 | -1.26 % | $ 464 M |  Curacao |
 |
Cytosorbents Corporation
CTSO
|
-43.74 | $ 0.7 | 3.3 % | $ 38.1 M | USA |
 |
Aethlon Medical
AEMD
|
-181.91 | $ 2.16 | -6.09 % | $ 3.37 M | USA |
 |
Profound Medical Corp.
PROF
|
-35.38 | $ 5.15 | -4.63 % | $ 180 M | Canada |
 |
BIOLASE
BIOL
|
-58.78 | - | -13.19 % | $ 166 K | USA |
 |
Penumbra
PEN
|
9.73 | $ 334.17 | -0.41 % | $ 13 B | USA |
 |
AdaptHealth Corp.
AHCO
|
-1.64 | $ 11.48 | 10.7 % | $ 1.55 B | USA |
 |
Myomo
MYO
|
-40.31 | $ 0.7 | -1.83 % | $ 29.3 M | USA |
 |
Insulet Corporation
PODD
|
7.75 | $ 225.5 | -0.7 % | $ 15.9 B | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-25.48 | $ 2.4 | -1.64 % | $ 141 M | Israel |
 |
Invacare Corporation
IVC
|
-2.67 | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-22.1 | $ 3.91 | 4.83 % | $ 146 M |  France |
 |
Quanterix Corporation
QTRX
|
-25.59 | $ 3.82 | -3.05 % | $ 163 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-7.8 | $ 15.91 | -3.4 % | $ 373 M | USA |
 |
Outset Medical
OM
|
-30.87 | $ 3.53 | -2.35 % | $ 53.7 K | USA |